Connection

Payam Tabarsi to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications Payam Tabarsi has written about Aged, 80 and over.
Payam Tabarsi
Connection Strength
0.101
Aged, 80 and over
  1. Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329.
    View in: PubMed
    Score: 0.026
  2. Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. Int Immunopharmacol. 2020 Dec; 89(Pt B):107102.
    View in: PubMed
    Score: 0.025
  3. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
    View in: PubMed
    Score: 0.025
  4. Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial. Int Immunopharmacol. 2021 Oct; 99:108043.
    View in: PubMed
    Score: 0.007
  5. Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727.
    View in: PubMed
    Score: 0.007
  6. Silent hypoxia: higher NO in red blood cells of COVID-19 patients. BMC Pulm Med. 2020 Oct 16; 20(1):269.
    View in: PubMed
    Score: 0.006
  7. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. Transfus Apher Sci. 2020 Oct; 59(5):102875.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.